Starbloom Capital focuses its investments on breakthrough innovations within deep tech, including longevity biotech, neuroAI, and other emerging industries. The firm's strategy involves partnering with visionary founders at the seed and early stages, primarily in the United States and United Kingdom, who are advancing the frontiers of science, technology, and human potential.
100% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is series-a (100% of deals).
Portfolio
1
Fund Size
$289M
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Bexorg, Inc. | Series A | $23M | Oct 2025 |
Top Co-Investors
Last updated: 28 April 2026